Several vaccines were approved after COVID-19 pandemic, which have been fast-tracked for emergency use. The short- and long-term safety profile has been an area of concern. We presented a patient with encephalitis followed by hyponatremia who developed hallucination and seizure 1 day after receiving the second dose of Sinopharm vaccine.
Keywords: COVID‐19 vaccine; SADH; Sinopharm BIBP; encephalitis; hyponatremia.
© 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.